[1] SUNG C Y W,HAYASE N,YUEN P S T,et al. Macrophage depletion protects against cisplatin-induced ototoxicity and nephrotoxicity[J]. Sci Adv,2024,10(30):eadk9878. [2] GHOSH S.Cisplatin: The first metal based anticancer drug[J]. Bioorg Chem,2019,88:102925. [3] ZHANG X,TRENDOWSKI M R,WILKINSON E,et al.Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss,tinnitus,and peripheral sensory neuropathy[J]. Cancer Med,2022,11(14):2801-2816. [4] HODGE S E,LOPEZ I A,ISHIYAMA G,et al.Cisplatin ototoxicity histopathology[J]. Laryngoscope Investig Otolaryngol,2021,6(4):852-856. [5] QIAO X,HE Y,LI W,et al.20(S)-Ginsenoside Rh1 inhibits cisplatin-induced hearing loss by inhibiting the MAPK signaling pathway and suppressing apoptosis in vitro[J]. Biochim Biophys Acta Mol Cell Res,2023,1870(5):119461. [6] BREGLIO A M,RUSHEEN A E,SHIDE E D,et al.Cisplatin is retained in the cochlea indefinitely following chemotherapy[J]. Nat Commun,2017,8(1):1654. [7] TAN W J T,VLAJKOVIC S M. Molecular characteristics of cisplatin-induced ototoxicity and therapeutic interventions[J]. Int J Mol Sci,2023,24(22):16545. [8] WANG X,ZHOU Y,WANG D,et al.Cisplatin-induced ototoxicity: From signaling network to therapeutic targets[J]. Biomed Pharmacother,2023,157:114045. [9] SANTOS N A G D,FERREIRA R S,SANTOS A C D. Overview of cisplatin-induced neurotoxicity and ototoxicity,and the protective agents[J]. Food Chem Toxicol,2020,136:111079. [10] TANG Q,WANG X,JIN H,et al.Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies[J]. Eur J Pharm Biopharm,2021,163:60-71. [11] ZAHEDI K,BARONE S,DESTEFANO-SHIELDS C,et al.Activation of endoplasmic reticulum stress response by enhanced polyamine catabolism is important in the mediation of cisplatin-induced acute kidney injury[J]. PLoS One,2017,12(9):e0184570. [12] 邱悦,程诚,卢洁,等. 体外顺铂损伤HEI-OC1细胞线粒体功能的研究[J]. 中华耳科学杂志,2024,22(6):1006-1010. QIU Y,CHENG C,LU J,et al.Cisplatin-induced mitochondrial function damage in HEI-OC1 cells[J]. Chin J Otol,2024,22(6):1006-1010. [13] HE Y,ZHENG Z,LIU C,et al.Inhibiting DNA methylation alleviates cisplatin-induced hearing loss by decreasing oxidative stress-induced mitochondria-dependent apoptosis via the LRP1-PI3K/AKT pathway[J]. Acta Pharm Sin B,2022,12(3):1305-1321. [14] 赵宇亮,李熙星. 顺铂耳毒性机制及耳保护策略研究进展[J]. 中华耳科学杂志,2021,19(1):167-171. ZHAO Y L,LI X X.Progress in research on protection strategies against and mechanisms of cisplatin ototoxicity[J]. Chin J Otol,2021,19(1):167-171. [15] XU F L,CHENG Y,YAN W.Up-regulation of autophagy and apoptosis of cochlear hair cells in mouse models for deafness[J]. Arch Med Sci,2021,17(2):535-541. [16] RAMKUMAR V,MUKHERJEA D,DHUKHWA A,et al.Oxidative stress and inflammation caused by cisplatin ototoxicity[J]. Antioxidants (Basel),2021,10(12):1919. [17] SIES H.Oxidative stress: a concept in redox biology and medicine[J]. Redox Biol,2015,4:180-183. [18] CECERSKA-HERYĆ E,SUROWSKA O,HERYĆ R,et al.Are antioxidant enzymes essential markers in the diagnosis and monitoring of cancer patients-A review[J]. Clin Biochem,2021,93:1-8. [19] CASERO R A Jr,MURRAY STEWART T,PEGG A E. Polyamine metabolism and cancer: Treatments,challenges and opportunities[J]. Nat Rev Cancer,2018,18(11):681-695. [20] KALINEC G,THEIN P,PARK C,et al.HEI-OC1 cells as a model for investigating drug cytotoxicity[J]. Hear Res,2016,335:105-117. |